Source: CME Online 2014
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Du Bois, B. Crestani. Idiopathic Pulmonary Fibrosis: understanding the natural course of the disease. CME Online 2014

Member's Comments

No comment yet.

Related content which might interest you: Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016 IPF - Idiopathic Pulmonary Fibrosis Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152 Year: 2019 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 Idiopathic pulmonary fibrosis: a treatable disease? Source: Eur Respir J 2003 Dec 01;22(6):872-873 Year: 2003 Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016 Year: 2017 Impact of depression on patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 The role of infection in acute exacerbation of Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Serum ST2 in Idiopathic Pulmonary Fibrosis (IPF): a possible new biomarker of disease? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort Source: International Congress 2014 – ILDs 4 Year: 2014